Osborne Clarke advises Accelovance Inc on its multimarket agreement to acquire THERAMetrics CRO operations
Accelovance Inc is an award winning, clinical development CRO focused on vaccine, oncology, and general medicine Phase I-IV programs. As...
Published on
26/05/2016
Read time
1m